Posters
Glomerular Diseases: Complement-Mediated Glomerulopathies and Infection-Related GN
October 24, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Complement-Mediated Thrombotic Microangiopathy in Scleroderma Renal Crisis with CFH-H3 Risk Haplotype and Response to C5 Blockade
Thrombotic Microangiopathy in Anti-Antimelanoma Differentiation-Associated Gene 5 Antibody (MDA5) Dermatomyositis: An Unusual Kidney Complication
Tonsillectomy-Associated Remission of C3 Glomerulonephritis: A Mucosal-Complement Link?
Successful Withdrawal of Complement Inhibition in Atypical Hemolytic Uremic Syndrome with Complement Gene Variants: A Pediatric Case Series
A Diagnostic Conundrum: An Unusual Case of Cryoglobulinemic Glomerulonephritis in a Patient with Full-House Nephropathy
C3-Dominant Glomerulonephritis Mimicking Malignant Nephrosclerosis in Hypertensive Emergency
C3 Glomerulonephritis After Candida parapsilosis Lung Infection
Nivolumab-Induced Membranoproliferative Glomerulonephritis with Nephrotic Syndrome
Similar Onset, Divergent Outcomes: Two Cases of Thrombotic Microangiopathy Masquerading as Fulminant Myocarditis
Immunotactoid Glomerulopathy in a Patient with Diffuse Large B-Cell Lymphoma and Untreated Hepatitis C
First Documented Use of Pegcetacoplan for Fibrillary Glomerulonephritis: A Case Report
Fibrillary Glomerulonephritis in a Patient with Concurrent Diabetic Nephropathy and Misleading Serology: Importance of Tissue Diagnosis
A Familial Case Highlights the Necessity of Biomarker Determination Alongside Genetic Testing in C3 Glomerulopathy, Age-Related Macular Degeneration, and Neuromyelitis Optica Spectrum Disorder
IgM Nephropathy in Older Patients: Severe Steroid Myopathy Prompting Rituximab Rescue in an Understudied Entity
Beyond Acute Interstitial Nephritis: C3 Glomerulopathy as a Rare and Underrecognized Face of Immunotherapy Nephrotoxicity
Fifteen Years in Hiding: DNAJB9-Positive Fibrillary Glomerulonephritis Emerging from the Shadow of Membranous Nephropathy
Immunofluorescence Unmasks C3-Dominant Glomerulonephritis in an Electron Microscopy (EM)-Negative Biopsy
PR3-ANCA Positivity Without Vasculitis: IgM-Dominant Immune Complex Glomerulonephritis Revealing Subacute Bartonella Endocarditis
Atypical Presentation of C3 Glomerulopathy in a 28-Year-Old Man
What to Do, Oh What to Do, to Get the Fibrillary out of You
Real-World Response to Pegcetacoplan in C3 Glomerulopathy: A Two-Case Report
Refractory C3 Glomerulonephritis with Rapid Clinical and Biochemical Response to Pegcetacoplan After Failure of Eculizumab and Mycophenolate
Steroid-Responsive Cryofibrinogen-Associated Kidney Disease: A Case of Relapse and Remission
Revisiting the Diagnosis: Fibrillary Glomerulonephritis in a Patient Initially Diagnosed with Anti-GBM Disease
More Than a Typical Postinfectious Glomerulonephritis: The Complement Connection
A Case of Paraneoplastic Immune Complex-Mediated Membranoproliferative Glomerulonephritis Due to High-Grade Prostate Small-Cell Neuroendocrine Carcinoma
Posterior Encephalopathy Syndrome (PRES) in Hepatitis C Virus (HCV)-Associated Seronegative Cryoglobulinemia and Active Hepatitis C: A Diagnostic and Therapeutic Challenge
Not Hepatorenal Syndrome: Fibrillary Glomerulonephritis Despite Virologic Cure of Hepatitis C
A Case of C3 Glomerulopathy
The Wolf in C3's Clothing: Unmasking Subacute Endocarditis in a C3 Glomerulopathy Masquerade
Fibrillary Glomerulonephritis with Focal Crescents and Concurrent c-ANCA, p-ANCA, and Myeloperoxidase (MPO) Positivity
The Complement Paradox: C3 Glomerulonephritis with Normal C3 and Recovery Without Immunosuppressive Therapy
A Case of Terminal Complement Pathway Dysregulation in C3 Glomerulonephritis
Post-Strep Fallout: Severe Post-Streptococcal Glomerulonephritis (PSGN) After Streptococcal Bacteremia in an Adult
The Glomerulus That Refused to Quit: Renal Recovery in HIV-Associated Nephropathy (HIVAN)
Fibrillary Glomerulonephritis in a Patient with Appendiceal Carcinoma
MCP/CD46 Allele-Associated Renal-Limited Thrombotic Microangiopathy: A Case Suggestive of Complement-Mediated Disease
Caught in the Complement Cascade: A Challenging Case of C1q Nephropathy
A Rare Case of C3 Glomerulonephritis in a 45-Year-Old Filipino Man with Type 2 Diabetes
Essential Mixed Cryoglobulinemic Membranoproliferative Glomerulonephritis Masquerading as Cardiorenal Syndrome
Fulminant Cryoglobulinemic Glomerulonephritis Seven Years After Viral Eradication: A Case Report
C3 Nephropathy with Classic Pathway Involvement Responding to Iptacopan
Not All Angioedema on an ACE Inhibitor Is ACE Inhibitor Angioedema
A Pill with Unexpected Consequences: Drug-Induced Thrombotic Microangiopathy with a Single Nonsteroidal Anti-Inflammatory Drug (NSAID) Dose
A Diagnostic Challenge: Hepatitis C Virus (HCV)-Associated Membranoproliferative Glomerulonephritis in the Setting of Multiple Comorbidities
Fibrillary Glomerulonephritis Presenting as Isolated Microscopic Hematuria with Minimal Proteinuria
B-Cell-Depleting Therapies in C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative Glomerulonephritis as a Treatment Option
Late-Onset C3 Glomerulopathy with Atypical Features and Response to Conservative Therapy
Cryoglobulinemic Glomerulonephritis in a Patient with Treated Hepatitis C
Severe Postinfectious Glomerulonephritis: Steroid Benefit at a Cost
C3 Glomerulonephritis with High PR3 Titer Successfully Treated with Pegcetacoplan
Long-Term Eculizumab Treatment Failure in C3 Glomerulonephritis: Effect of Persistent Upstream Complement Activation
IgM-Dominant Glomerulonephritis Unmasking Seronegative Rheumatoid Arthritis
Rheumatoid Arthritis-Associated Membranoproliferative Glomerulonephritis Presenting as Nephrotic Syndrome and AKI
Crescentic Fibrillary Glomerulonephritis with Severe AKI: Renal Recovery After Rituximab Induction
When Immunosuppression Fails: Persistent Complement Activation in Aggressive Dense Deposit Disease
Improvement in eGFR Slope with Iptacopan in C3 Glomerulonephritis with Complement Factor B Variant
Potential Benefit of Clone-Directed Therapy in C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) Despite Unresolved Mechanistic Pathways
Type II Cryoglobulinemic Glomerulonephritis Presenting with Near Full-House Immunofluorescence